Table 3.
Variable | One-Year Survival (95% CI) | Five-Year Survival (95% CI) |
---|---|---|
Overall | 87% (0.82–0.92) | 70% (0.63–0.77) |
Age (y) | ||
<10 | 86% (0.75–0.98) | 67% (0.53–0.85) |
≥10 | 88% (0.82–0.93) | 70% (0.63–0.79) |
Gender | ||
Female | 93% (0.88–0.99) | 76% (0.66–0.86) |
Male | 83% (0.76–0.91) | 66% (0.57–0.76) |
Nodal status | ||
Positive | 79% (0.68–0.91) | 55% (0.42–0.71) |
Negative | 95% (0.90–0.99) | 83% (0.76–0.92) |
Path stage | ||
I | 100% (1.0–1.0) | 100% (1.0–1.0) |
II | 100% (1.0–1.0) | 91% (0.79–1.0) |
III | 93% (0.86–1.0) | 71% (0.58–0.86) |
IV | 55% (0.34–0.90) | 8% (0.01–0.52) |
Resection type | ||
No resection | 35% (0.20–0.64) | 20% (0.08–0.48) |
Partial nephrectomy | 100% (1.0–1.0) | 100% (1.0–1.0) |
Complete nephrectomy | 95% (0.91–0.99) | 79% (0.72–0.87) |
Tumor size (cm) | ||
≤4 | 93% (0.86–0.99) | 89% (0.81–0.98) |
4.1–7 | 100% (1.0–1.0) | 88% (0.78–1.0) |
7.1–10 | 85% (0.74–0.98) | 60% (0.45–0.80) |
>10 | 85% (0.73–1.0) | 50% (0.34–0.74) |